Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma
在滤泡性淋巴瘤患者首次缓解期接种患者特异性肿瘤衍生抗原疫苗可提高无病生存期。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2010.33.3005
Schuster, Stephen J; Neelapu, Sattva S; Gause, Barry L; Janik, John E; Muggia, Franco M; Gockerman, Jon P; Winter, Jane N; Flowers, Christopher R; Nikcevich, Daniel A; Sotomayor, Eduardo M; McGaughey, Dean S; Jaffe, Elaine S; Chong, Elise A; Reynolds, Craig W; Berry, Donald A; Santos, Carlos F; Popa, Mihaela A; McCord, Amy M; Kwak, Larry W